Windlas Biotech peers

Companies like Windlas Biotechlatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

WINDLAS₹888.70

Windlas Biotech Limited

· Pharma & Health
₹ CrorePeersHESTERBIOINDOCOSAIPARENTSYNCOMFPANACEABIONGLFINEHIKALJAGSNPHARMMcap ₹1,876 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
WINDLAS
FY26
HESTERBIO
FY26
INDOCO
FY26
SAIPARENT
FY26
Peer
Average
Valuation — at last close
P/E◆ 28.13×36.64×—94.36×65.50× -57%
P/B3.23×4.96×◆ 1.79×4.39×3.71× -13%
EV/EBITDA◆ 15.62×27.30×16.92×60.87×35.03× -55%
Market Cap₹1,876 Cr₹1,909 Cr₹1,973 Cr₹2,139 Cr₹2,007 Cr -7%
Growth
Revenue CAGR 3Y◆ 20.78%4.77%0.39%—2.58% +705%
Revenue CAGR 5Y—◆ 6.98%6.33%—6.66%
Net Income CAGR 3Y15.93%◆ 17.23%——17.23% -8%
Revenue YoY (latest Q)◆ 18.09%14.44%2.14%—8.29% +118%
Net Income YoY (latest Q)-0.07%87.69%◆ 103.52%—95.60% -100%
Profitability
EBITDA Margin11.58%◆ 24.81%9.32%18.85%17.66% -34%
Net Income Margin7.35%◆ 17.83%-0.34%10.34%9.28% -21%
Return on Common Equity12.23%◆ 14.39%-0.51%3.45%5.78% +112%
Return on Capital Employed13.48%◆ 13.60%3.35%4.67%7.21% +87%
Return on Assets7.97%◆ 9.44%-0.25%2.09%3.76% +112%
Credit & Quality
Total Debt/Equity◆ 0.05×0.19×0.64×0.27×0.37× -86%
Interest Coverage◆ 15.33×8.68×0.57×2.83×4.03× +281%
Scale — latest FY
Revenue / Total Income₹904 Cr₹292 Cr₹1,686 Cr₹162 Cr₹713 Cr +27%
Net Income₹66.4 Cr₹52.1 Cr−₹5.7 Cr₹16.8 Cr₹21.1 Cr +215%
Total Assets₹907 Cr₹557 Cr₹2,365 Cr₹804 Cr₹1,242 Cr -27%
EPS₹31.59₹61.24₹-0.61₹5.13₹21.92 +44%
Book Value per Share₹275.2₹452.78₹119.09₹110.23₹227.37 +21%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.